SB240 (2023) Detail

Relative to conditions for genetic testing.


CHAPTER 230

SB 240 - FINAL VERSION

 

03/09/2023   0579s

8Jun2023... 1954h

 

2023 SESSION

23-0991

05/04

 

SENATE BILL 240

 

AN ACT relative to conditions for genetic testing.

 

SPONSORS: Sen. Prentiss, Dist 5; Sen. Perkins Kwoka, Dist 21; Sen. Watters, Dist 4; Sen. Fenton, Dist 10; Rep. Cormen, Graf. 15; Rep. Morse, Graf. 9

 

COMMITTEE: Health and Human Services

 

─────────────────────────────────────────────────────────────────

 

AMENDED ANALYSIS

 

This bill permits disclosure of genetic testing or genetic analysis to clinical entities participating in the clinical care of the patient.  The bill clarifies that specific informed consent from the patient is required when such disclosure is made for clinical research purposes.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

03/09/2023   0579s

8Jun2023... 1954h 23-0991

05/04

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Three

 

AN ACT relative to conditions for genetic testing.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

230:1  Conditions of Genetic Testing.  RSA 141-H:2, IV is repealed and reenacted to read as follows:

IV.(a)  Nothing in this section shall limit genetic testing or genetic analysis used for diagnosis and treatment of a consenting patient by a clinical laboratory that has received a specimen referral from the individual patient's treating physician, genetic counselor, or another clinical laboratory.

(b)  This section allows for the disclosure of genetic testing or genetic analysis to entities participating in the clinical care of the patient.  

(c)  Nothing in this section shall be construed to waive the requirement that the treating physician obtain specific informed patient consent in accordance with the provisions of this section for clinical research.

230:2  Effective Date.  This act shall take effect 60 days after its passage.

 

Approved: August 04, 2023

Effective Date: October 03, 2023

Amendments

Date Amendment
Feb. 16, 2023 2023-0579s
May 31, 2023 2023-1954h

Links


Date Body Type
Feb. 16, 2023 Senate Hearing
Feb. 23, 2023 Senate Floor Vote
Feb. 22, 2023 Senate Floor Vote
March 9, 2023 Senate Floor Vote
March 9, 2023 Senate Floor Vote
April 5, 2023 House Hearing
April 26, 2023 House Exec Session
May 3, 2023 House Exec Session
May 10, 2023 House Exec Session
May 24, 2023 House Exec Session
May 23, 2023 House Floor Vote

Bill Text Revisions

SB240 Revision: 39381 Date: Aug. 9, 2023, 8:59 a.m.
SB240 Revision: 39149 Date: June 15, 2023, 4:06 p.m.
SB240 Revision: 39061 Date: June 8, 2023, 1:31 p.m.
SB240 Revision: 38914 Date: May 31, 2023, 11:18 a.m.
SB240 Revision: 38168 Date: March 9, 2023, 1:06 p.m.
SB240 Revision: 37975 Date: Feb. 16, 2023, 4:07 p.m.
SB240 Revision: 37726 Date: Jan. 24, 2023, 11:28 a.m.

Docket


Aug. 9, 2023: Signed by the Governor on 08/04/2023; Chapter 0230; Effective 10/03/2023


July 18, 2023: Enrolled Adopted, VV, (In recess 06/29/2023); SJ 20


July 19, 2023: Enrolled (in recess of) 06/29/2023 HJ 17


July 19, 2023: Enrolled (in recess of) 06/29/2023 HJ 17 P. 18


July 18, 2023: Enrolled Adopted, VV, (In recess 06/29/2023); SJ 20


June 15, 2023: Sen. Birdsell Moved to Concur with the House Amendment, MA, VV; 06/15/2023; SJ 19


June 8, 2023: Ought to Pass with Amendment 2023-1954h: MA VV 06/08/2023 HJ 15 P. 9


June 8, 2023: Amendment # 2023-1954h: AA VV 06/08/2023 HJ 15 P. 9


May 31, 2023: Committee Report: Ought to Pass with Amendment # 2023-1954h 05/23/2023 (Vote 20-0; CC)


May 18, 2023: ==CONTINUED== Executive Session: 05/24/2023 11:00 am LOB 205-207


May 10, 2023: Subcommittee Work Session: 05/16/2023 10:30 am LOB 205-207


May 4, 2023: ==RECESSED== Executive Session: 05/10/2023 11:00 am LOB 205-207


May 4, 2023: Subcommittee Work Session: 05/10/2023 10:00 am LOB 205-207


April 26, 2023: ==RECESSED== Executive Session: 05/03/2023 09:30 am LOB 201-203


April 19, 2023: ==RECESSED== Executive Session: 04/26/2023 09:30 am LOB 205-207


March 29, 2023: Public Hearing: 04/04/2023 11:00 am LOB 205-207


March 20, 2023: Introduced (in recess of) 03/16/2023 and referred to Health, Human Services and Elderly Affairs


March 9, 2023: Ought to Pass with Amendment 2023-0579s, MA, VV; OT3rdg; 03/09/2023; SJ 9


March 9, 2023: Committee Amendment # 2023-0579s, AA, VV; 03/09/2023; SJ 9


Feb. 22, 2023: Committee Report: Ought to Pass, 03/09/2023; SJ 8


Feb. 22, 2023: Committee Report: Ought to Pass with Amendment # 2023-0579s, 03/09/2023; SC 12


Feb. 22, 2023: Special Order to 03/09/2023, Without Objection, MA; 02/22/2023 SJ 8


Feb. 22, 2023: Sen. Rosenwald Moved to Remove SB 240 from the Consent Calendar; 02/22/2023; SJ 8


Feb. 16, 2023: Committee Report: Ought to Pass with Amendment # 2023-0579s, 02/22/2023; Vote 5-0; CC; SC 11


Feb. 8, 2023: Hearing: 02/16/2023, Room 101, LOB, 09:45 am; SC 10


Jan. 24, 2023: Introduced 01/19/2023 and Referred to Health and Human Services; SJ 5